Exploration of synergistically engineered invasomes of fluconazole incorporated with safranal against onychomycosis for enhanced transungual delivery
The present study supported the claim that the developed invasomal formulation is a desirable vesicular carrier for FLU transungual delivery for the management of onychomycosis.
Authors
- Syeda Nashvia Adin (ORCID: https://orcid.org/0000-0002-7857-1124)
- Mohd Mujeeb (ORCID: https://orcid.org/0000-0003-3110-6089)
- Isha Gupta (ORCID: https://orcid.org/0000-0002-2987-2967)
- Mohd. Aqil (ORCID: https://orcid.org/0000-0001-6797-3104)
Institutions
- Jamia Hamdard (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1080/03639045.2024.2437050
- Citations
- 2
- Primary Topic
- Nail Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.77